viWTA Blootstelling aan niet-ioniserende straling in huis - Instituut ...
viWTA Blootstelling aan niet-ioniserende straling in huis - Instituut ...
viWTA Blootstelling aan niet-ioniserende straling in huis - Instituut ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2.6.1 Basisrestricties en referentienieveaus.................................................. 32<br />
2.6.2 Normer<strong>in</strong>gsorganen ............................................................................. 33<br />
2.6.2.1 ICNIRP.......................................................................................... 33<br />
2.6.2.2 WHO ............................................................................................. 33<br />
2.6.2.3 Europa .......................................................................................... 34<br />
2.6.2.4 België............................................................................................ 34<br />
2.6.2.5 TCO............................................................................................... 34<br />
2.6.3 Statische velden en extreem lage frequenties (ELF)............................ 35<br />
2.6.3.1 Basisrestricties .............................................................................. 35<br />
2.6.3.2 Referentieniveaus ......................................................................... 35<br />
2.6.3.3 Bronspecifieke regelgev<strong>in</strong>g ........................................................... 36<br />
2.6.4 Intermediaire frequenties .................................................................... 37<br />
2.6.4.1 Basisrestricties .............................................................................. 37<br />
2.6.4.2 Referentieniveaus ......................................................................... 37<br />
2.6.5 Radiofrequente velden......................................................................... 37<br />
2.6.5.1 Basisrestricties .............................................................................. 37<br />
2.6.5.2 Referentieniveaus ......................................................................... 38<br />
2.6.5.3 Microgolfoven ............................................................................... 41<br />
2.6.6 UV <strong>stral<strong>in</strong>g</strong> ........................................................................................... 41<br />
2.6.7 Infrarood.............................................................................................. 42<br />
2.6.8 Lasers .................................................................................................. 43<br />
2.7 Samenvatt<strong>in</strong>g .............................................................................................. 45<br />
3 BLOK B: Impact.................................................................................................. 47<br />
3.1 Enkele positieve toepass<strong>in</strong>gen van elektromagnetische velden .................. 47<br />
3.2 Algemene begrippen ................................................................................... 47<br />
3.2.1 Biologisch effect / gezondheidseffect .................................................. 47<br />
3.2.2 In vitro studies..................................................................................... 48<br />
3.2.3 In vivo studies ..................................................................................... 48<br />
3.2.4 Epidemiologische studies ..................................................................... 48<br />
3.3 Typologie van risico’s.................................................................................. 49<br />
3.3.1 Statische elektromagnetische velden................................................... 49<br />
3.3.1.1 Interactie met het lichaam ........................................................... 49<br />
3.3.1.2 Gezondheidseffecten .................................................................... 49<br />
3.3.2 Extreem lage frequenties (ELF) ........................................................... 50<br />
3.3.2.1 Effecten op korte termijn.............................................................. 50<br />
3.3.2.2 In vitro studies.............................................................................. 51<br />
3.3.2.3 In vivo studies .............................................................................. 51<br />
3.3.2.4 Epidemiologische studies.............................................................. 52<br />
3.3.2.5 Ribbel- of deukdijen (Lipoatrophia semicircularis)........................ 53<br />
3.3.2.6 Overzicht effecten......................................................................... 54<br />
3.3.3 Intermediaire frequenties (IF) ............................................................. 55<br />
3.3.4 Radiofrequente velden......................................................................... 55<br />
3.3.4.1 Algemeen...................................................................................... 55<br />
3.3.4.2 Kanker epidemiologie ................................................................... 55<br />
3.3.4.3 In vivo onderzoek (proefdieren) ................................................... 58<br />
3.3.4.4 Genotoxische effecten (<strong>in</strong> vitro) ................................................... 59<br />
3.3.4.5 Expressie van genen..................................................................... 60<br />
3.3.4.6 Experimenteel onderzoek (mensen) ............................................. 61<br />
3.3.4.7 Blood-bra<strong>in</strong>-barrier (BBB) ............................................................. 62<br />
3.3.4.8 Besluit........................................................................................... 63<br />
3.3.5 UV en <strong>in</strong>frarood.................................................................................... 64<br />
3.3.5.1 UV <strong>stral<strong>in</strong>g</strong> .................................................................................... 64